An integrative review on the risk factors, prevention, and control strategies for carbapenem-resistant Acinetobacter baumannii colonization in critically ill patients
- PMID: 39867493
- PMCID: PMC11757275
- DOI: 10.3389/fmicb.2024.1519906
An integrative review on the risk factors, prevention, and control strategies for carbapenem-resistant Acinetobacter baumannii colonization in critically ill patients
Abstract
The presence of carbapenem-resistant Acinetobacter baumannii (CRAb) has become one of the leading causes of life-threatening, hospital-acquired infections globally, especially with a notable prevalence in intensive care units (ICUs). The cross-transmission of microorganisms between patients and the hospital setting is crucial in the development of CRAb colonization and subsequent infections. Recent studies indicate that colonization typically precedes infection, suggesting the effectiveness and necessity of preventing CRAb colonization as a primary method to lower infection risks. As CRAb infections tend to draw more attention due to their severe symptoms and poor outcomes, understanding the link between colonization and infection is equally vital. To establish a foundation for prevention and control strategies against CRAb colonization in ICUs, we present a comprehensive review of research pertaining to CRAb in ICUs. This encompasses an analysis of the resistance mechanisms and epidemiological characteristics of CRAb, a discussion on associated risk factors, adverse outcomes, and an evaluation of detection methods and preventive strategies.
Keywords: CRAb; colonization; hazard; prevention; risk factors.
Copyright © 2025 Zhang, Xiao, Li, Li, Li, Pang, Yan, Han, Cui, Zhang and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit.Front Microbiol. 2022 Nov 10;13:1045206. doi: 10.3389/fmicb.2022.1045206. eCollection 2022. Front Microbiol. 2022. PMID: 36439795 Free PMC article. Review.
-
Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in Milan, Italy.Microbiol Spectr. 2023 Mar 28;11(2):e0020923. doi: 10.1128/spectrum.00209-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 36976013 Free PMC article.
-
Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children.Front Public Health. 2023 Nov 30;11:1282413. doi: 10.3389/fpubh.2023.1282413. eCollection 2023. Front Public Health. 2023. PMID: 38098829 Free PMC article.
-
Epidemiological and genetic characteristics of clinical carbapenem-resistant Acinetobacter baumannii strains collected countrywide from hospital intensive care units (ICUs) in China.Emerg Microbes Infect. 2022 Dec;11(1):1730-1741. doi: 10.1080/22221751.2022.2093134. Emerg Microbes Infect. 2022. PMID: 35730377 Free PMC article.
-
The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis.Emerg Microbes Infect. 2019;8(1):1747-1759. doi: 10.1080/22221751.2019.1698273. Emerg Microbes Infect. 2019. PMID: 31805829 Free PMC article.
Cited by
-
Therapeutic efficacy and mechanisms of Xuebijing in Acinetobacter baumannii infection based on meta-analysis and integrated pharmacology approaches.Front Pharmacol. 2025 May 23;16:1598359. doi: 10.3389/fphar.2025.1598359. eCollection 2025. Front Pharmacol. 2025. PMID: 40487407 Free PMC article.
References
-
- Agustí C., Pujol M., Argerich M. J., Ayats J., Badía M., Domínguez M. A., et al. (2002). Short-term effect of the application of selective decontamination of the digestive tract on different body site reservoir ICU patients colonized by multi-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 49 205–208. 10.1093/jac/49.1.205 - DOI - PubMed
-
- Alfandari S., Gois J., Delannoy P. Y., Georges H., Boussekey N., Chiche A., et al. (2014). Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. Med. Mal. Infect. 44 229–231. - PubMed
-
- Al-Hamad A., Pal T., Leskafi H., Abbas H., Hejles H., Alsubikhy F., et al. (2020). Molecular characterization of clinical and environmental carbapenem resistant Acinetobacter baumannii isolates in a hospital of the Eastern Region of Saudi Arabia. J. Infect. Public Health 13 632–636. 10.1016/j.jiph.2019.08.013 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials